Mereo BioPharma Group Ownership | Who Owns Mereo BioPharma Group?
Mereo BioPharma Group Ownership Summary
Mereo BioPharma Group is owned by 14.35% institutional investors, 1.03% insiders, and 84.62% retail investors. Rubric capital management lp is the largest institutional shareholder, holding 2.19% of MREO shares. Tema Obesity & Cardiometabolic ETF is the top mutual fund, with 0.34% of its assets in Mereo BioPharma Group shares.
MREO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Mereo BioPharma Group | 14.35% | 1.03% | 84.62% |
| Sector | Healthcare Stocks | 47.06% | 8.01% | 44.93% |
| Industry | Biotech Stocks | 44.97% | 7.82% | 47.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Rubric capital management lp | 15.31M | 2.19% | $55.11M |
| Adage capital partners gp | 11.79M | 1.68% | $42.45M |
| Rock springs capital management lp | 9.28M | 1.33% | $33.42M |
| Mangrove partners | 8.75M | 1.25% | $31.51M |
| Janus henderson group | 7.88M | 1.13% | $28.41M |
| Deerfield management company, l.p. (series c) | 6.71M | 0.96% | $24.16M |
| 683 capital management | 5.00M | 0.71% | $18.00M |
| Alkeon capital management | 4.70M | 0.67% | $16.91M |
| Frazier life sciences management | 4.40M | 0.63% | $15.84M |
| Clearline capital lp | 3.33M | 0.48% | $11.98M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Tejara capital | 2.62M | 3.42% | $9.42M |
| Mangrove partners | 8.75M | 2.42% | $31.51M |
| Acuta capital partners | 677.00K | 2.05% | $2.44M |
| Rubric capital management lp | 15.31M | 1.44% | $55.11M |
| 683 capital management | 5.00M | 1.36% | $18.00M |
| Rock springs capital management lp | 9.28M | 1.01% | $33.42M |
| Blue owl capital lp | 897.81K | 0.90% | $3.23M |
| Frazier life sciences management | 4.40M | 0.74% | $15.84M |
| Knoll capital management | 260.47K | 0.63% | $937.69K |
| Integral health asset management | 1.77M | 0.61% | $6.39M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deerfield management company, l.p. (series c) | 6.71M | 0.40% | 6.71M |
| Frazier life sciences management | 4.40M | 0.74% | 4.40M |
| Janus henderson group | 7.88M | 0.02% | 2.76M |
| Adage capital partners gp | 11.79M | 0.08% | 2.46M |
| Rubric capital management lp | 15.31M | 1.44% | 1.75M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Soleus capital management | 1.25M | 0.40% | -1.37M |
| Morgan stanley | 207.74K | 0.00% | -1.17M |
| Price t rowe associates inc /md/ | - | - | -991.97K |
| 683 capital management | 5.00M | 1.36% | -750.00K |
| Cantor fitzgerald, l. p. | - | - | -275.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Deerfield management company, l.p. (series c) | 6.71M | 0.40% | 6.71M | $24.16M |
| Frazier life sciences management | 4.40M | 0.74% | 4.40M | $15.84M |
| Perceptive advisors | 1.25M | 0.11% | 1.25M | $4.51M |
| Blue owl capital lp | 897.81K | 0.90% | 897.81K | $3.23M |
| Eversept partners, lp | 496.17K | 0.12% | 496.17K | $1.79M |
Sold Out
| Holder | Change |
|---|---|
| Plante moran financial advisors | -48.00 |
| Quadrant capital group | -398.00 |
| Ica group wealth management | -1.00K |
| Point72 asset management | -1.90K |
| Ariadne wealth management, lp | -3.50K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2024 | 80 | -4.76% | 100,517,090 | 19.63% | 14 | 8870446.46% | 34 | -33.33% | 27 | 125.00% |
| Mar 31, 2024 | 84 | 25.37% | 84,026,001 | 6.98% | - | 0.00% | 51 | 34.21% | 12 | 9.09% |
| Dec 31, 2023 | 67 | 17.54% | 78,543,746 | 11.37% | 65 | 1.91% | 38 | 100.00% | 11 | -35.29% |
| Sep 30, 2023 | 57 | 3.64% | 70,527,257 | 9.01% | 58 | 2.03% | 19 | 5.56% | 17 | -5.56% |
| Jun 30, 2023 | 55 | -6.78% | 64,699,909 | 6.39% | 53 | 2.11% | 18 | -18.18% | 18 | 38.46% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Tema Obesity & Cardiometabolic ETF | 524.03K | 0.34% | - |
| Tema Oncology ETF | 315.39K | 0.20% | - |
| HealthInvest Sustainable Healthcare E | 270.00K | 0.18% | 70.00K |
| Alger LIfe Sciences Innovation Composite | 186.65K | 0.12% | 78.05K |
| Fidelity Nasdaq Composite Index | 92.16K | 0.06% | - |
| PMC Diversified Equity | 55.90K | 0.04% | 8.73K |
| SPDR® S&P® International Small Cap ETF | 47.09K | 0.03% | - |
| Vanguard US Opportunities Ins USD Acc | 44.00K | 0.03% | - |
| ActivePassive International Equity ETF | 30.97K | 0.02% | -14.54K |
| Forefront Tiresias Strategy | 31.17K | 0.02% | 200.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 13, 2024 | Scots-Knight Denise | Chief Executive Officer | Sell | $253.45K |
| Sep 12, 2024 | Scots-Knight Denise | Chief Executive Officer | Sell | $127.97K |
| Sep 12, 2024 | Lewicki John A. | Chief Scientific Officer | Sell | $23.31K |
| Sep 13, 2024 | Lewicki John A. | Chief Scientific Officer | Sell | $46.17K |
| Sep 12, 2024 | Sermon Charles | General Counsel | Sell | $44.64K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q3 | - | 1 |
| 2024 Q2 | - | 12 |
| 2024 Q1 | - | - |
MREO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools